Investors

Please contact us for more information on investment opportunities and to learn more about our exciting research.
Scroll to Top

Dr Gulam Altab

CEO/CSO

Dr. Gulam Altab (BSc, MSc, MRes, and PhD) is a dedicated researcher specialising in the ageing of skeletal muscle and its response to caloric restriction. His PhD thesis focused on understanding the intricate changes in non-coding RNAs that occur during muscle ageing in rats. During this research, he aimed to identify key regulatory elements and biomarkers, with a specific focus on whether these changes could be influenced by dietary interventions, especially caloric restriction.

Gulam’s academic journey includes an MSc in Stem Cells and Regenerative Medicine and an MRes in Musculoskeletal Ageing. He has extensive experience in various research techniques and methodologies, including RNA sequencing, single-cell analysis, and molecular biology. He possesses a deep understanding of the complex cellular pathways and molecular mechanisms that underlie the ageing of tissues.

Currently, Gulam is deeply interested in the potential of targeted anti-ageing therapeutics. He firmly believes that slowing the ageing process is not only about extending our years but also enhancing the quality of our lives. It represents a journey towards a healthier, more fulfilling future.

“Slowing the ageing process is not just about increasing our lifespan; it’s an opportunity to improve our quality of life. It’s a path towards a healthier, more rewarding future.”